Longevity Machines: How Finance Is Rewriting the Rules of Life Extension
The market for longevity machines is reshaping the way investors, insurers, and biotech firms calculate risk and return. Once confined to speculative science fiction, the idea of extending human lifespan through engineered systems has become a measurable financial sector. Venture capital allocations, patent filings, and corporate R&D budgets all point to a clear shift: longevity machines are no longer a fringe concept but a defined asset class. At its core, the category
Read more→
Read more about Longevity Machines: How Finance Is Rewriting the Rules of Life Extension